Robeco Institutional Asset Management B.V. lessened its position in shares of Raymond James (NYSE:RJF - Free Report) by 50.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,953 shares of the financial services provider's stock after selling 10,116 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in Raymond James were worth $1,219,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of RJF. Heritage Wealth Advisors grew its stake in shares of Raymond James by 3,480.7% during the 1st quarter. Heritage Wealth Advisors now owns 488,258 shares of the financial services provider's stock worth $62,702,000 after purchasing an additional 474,622 shares during the period. Ceredex Value Advisors LLC grew its position in Raymond James by 191.3% during the third quarter. Ceredex Value Advisors LLC now owns 722,393 shares of the financial services provider's stock valued at $88,464,000 after buying an additional 474,443 shares during the period. AGF Management Ltd. increased its holdings in Raymond James by 17.2% in the second quarter. AGF Management Ltd. now owns 2,580,467 shares of the financial services provider's stock valued at $318,972,000 after buying an additional 378,033 shares in the last quarter. Earnest Partners LLC raised its position in shares of Raymond James by 5.9% in the first quarter. Earnest Partners LLC now owns 2,468,196 shares of the financial services provider's stock worth $316,966,000 after acquiring an additional 138,075 shares during the period. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH boosted its stake in shares of Raymond James by 34.4% during the 3rd quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 493,729 shares of the financial services provider's stock worth $60,462,000 after acquiring an additional 126,437 shares in the last quarter. Hedge funds and other institutional investors own 83.83% of the company's stock.
Analysts Set New Price Targets
Several brokerages recently weighed in on RJF. JMP Securities lifted their price target on Raymond James from $146.00 to $150.00 and gave the company a "market outperform" rating in a research note on Thursday, October 24th. Wells Fargo & Company boosted their price objective on Raymond James from $140.00 to $152.00 and gave the company an "overweight" rating in a research report on Thursday, October 24th. Bank of America increased their target price on Raymond James from $136.00 to $152.00 and gave the company a "buy" rating in a research report on Thursday, October 24th. Jefferies Financial Group boosted their price target on shares of Raymond James from $123.00 to $126.00 and gave the stock a "hold" rating in a report on Friday, October 4th. Finally, TD Cowen increased their price objective on shares of Raymond James from $128.00 to $150.00 and gave the company a "hold" rating in a report on Wednesday, October 30th. Nine analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $140.91.
Get Our Latest Report on RJF
Raymond James Price Performance
Shares of Raymond James stock traded up $3.98 on Monday, hitting $162.71. 687,341 shares of the company were exchanged, compared to its average volume of 1,145,412. The company has a quick ratio of 0.99, a current ratio of 1.02 and a debt-to-equity ratio of 0.41. The company has a 50-day moving average price of $130.92 and a 200 day moving average price of $123.16. The stock has a market capitalization of $33.51 billion, a price-to-earnings ratio of 16.77, a price-to-earnings-growth ratio of 0.80 and a beta of 0.99. Raymond James has a 1-year low of $99.06 and a 1-year high of $163.39.
Raymond James (NYSE:RJF - Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.95 earnings per share for the quarter, topping analysts' consensus estimates of $2.41 by $0.54. Raymond James had a return on equity of 19.61% and a net margin of 13.86%. The company had revenue of $3.46 billion for the quarter, compared to analyst estimates of $3.32 billion. During the same quarter in the previous year, the company posted $2.13 earnings per share. The firm's revenue for the quarter was up 13.4% compared to the same quarter last year. As a group, sell-side analysts predict that Raymond James will post 10.73 earnings per share for the current fiscal year.
Raymond James Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st were given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 1.11%. The ex-dividend date of this dividend was Tuesday, October 1st. Raymond James's payout ratio is currently 18.54%.
Raymond James Profile
(
Free Report)
Raymond James Financial, Inc, a financial holding company, through its subsidiaries, engages in the underwriting, distribution, trading, and brokerage of equity and debt securities, and the sale of mutual funds and other investment products in the United States, Canada, Europe, and internationally. The company operates through Private Client Group, Capital Markets, Asset Management, RJ Bank, and Other segments.
Read More
Before you consider Raymond James, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Raymond James wasn't on the list.
While Raymond James currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.